GP PHARM, S.A.

CRINESAL

Pharmaceutical preparations for human purposes for use in urology; pharmaceutical preparations for human purposes for the prevention and treatment of disorders of the nervous system; Pharmaceutical preparations for human purposes for the treatment of inflammatory disorders; Pharmaceutical preparations for human purposes for use in oncology and in tissue and organ transplantation; pharmaceutical preparations for human purposes for the treatment of viral, cardiovascular and psychiatric related diseases and disorders; pharmaceutical preparations for human purposes for the prevention and treatment of autoimmune diseases or disorders; Pharmaceutical preparations for human purposes, namely, peptides for use in urology, oncology and for the treatment of viral, inflammatory, nervous system, cardiovascular, psychiatric and autoimmune diseases or disorders;CRINE SAL;

DONILAR

Pharmaceutical preparations for human purposes for use in urology; pharmaceutical preparations for human purposes for the prevention and treatment of disorders of the nervous system; Pharmaceutical preparations for human purposes for the treatment of inflammatory disorders; Pharmaceutical preparations for human purposes for use in oncology and in tissue and organ transplantation; pharmaceutical preparations for human purposes for the treatment of viral, cardiovascular and psychiatric related diseases and disorders; pharmaceutical preparations for human purposes for the prevention and treatment of autoimmune diseases or disorders; peptides for use in urology, oncology and for the treatment of viral, inflammatory, nervous system, cardiovascular, psychiatric and autoimmune diseases or disorders;The wording DONILAR has no meaning in a foreign language.;

GEPRAL

Pharmaceutical preparations for human purposes for use in urology; pharmaceutical preparations for human purposes for the prevention and treatment of disorders of the nervous system; Pharmaceutical preparations for human purposes for the treatment of inflammatory disorders; Pharmaceutical preparations for human purposes for use in oncology and in tissue and organ transplantation; pharmaceutical preparations for human purposes for the treatment of viral, cardiovascular and psychiatric related diseases and disorders; pharmaceutical preparations for human purposes for the prevention and treatment of autoimmune diseases or disorders; peptides for use in urology, oncology and for the treatment of viral, inflammatory, nervous system, cardiovascular, psychiatric and autoimmune diseases or disorders;The wording GEPRAL has no meaning in a foreign language.;

GEPROTAX

Pharmaceutical preparations for human purposes for use in urology; pharmaceutical preparations for human purposes for the prevention and treatment of disorders of the nervous system; Pharmaceutical preparations for human purposes for the treatment of inflammatory disorders; Pharmaceutical preparations for human purposes for use in oncology and in tissue and organ transplantation; pharmaceutical preparations for human purposes for the treatment of viral, cardiovascular and psychiatric related diseases and disorders; pharmaceutical preparations for human purposes for the prevention and treatment of autoimmune diseases or disorders; Pharmaceutical preparations for human purposes, namely, peptides for use in urology, oncology and for the treatment of viral, inflammatory, nervous system, cardiovascular, psychiatric and autoimmune diseases or disorders;

GOTRATE

Pharmaceutical preparations for human purposes for use in urology; pharmaceutical preparations for human purposes for the prevention and treatment of disorders of the nervous system; Pharmaceutical preparations for human purposes for the treatment of inflammatory disorders; Pharmaceutical preparations for human purposes for use in oncology and in tissue and organ transplantation; pharmaceutical preparations for human purposes for the treatment of viral, cardiovascular and psychiatric related diseases and disorders; pharmaceutical preparations for human purposes for the prevention and treatment of autoimmune diseases or disorders; Pharmaceutical preparations for human purposes, namely, peptides for use in urology, oncology and for the treatment of viral, inflammatory, nervous system, cardiovascular, psychiatric and autoimmune diseases or disorders;GOT RATE;

MABLIP

Pharmaceutical preparations for human purposes for use in urology; pharmaceutical preparations for human purposes for the prevention and treatment of disorders of the nervous system; Pharmaceutical preparations for human purposes for the treatment of inflammatory disorders; Pharmaceutical preparations for human purposes for use in oncology and in tissue and organ transplantation; pharmaceutical preparations for human purposes for the treatment of viral, cardiovascular and psychiatric related diseases and disorders; pharmaceutical preparations for human purposes for the prevention and treatment of autoimmune diseases or disorders; Pharmaceutical preparations for human purposes, namely, peptides for use in urology, oncology and for the treatment of viral, inflammatory, nervous system, cardiovascular, psychiatric and autoimmune diseases or disorders;MAB LIP;

NICTUR

Pharmaceutical preparations for human use, in particular for use in nighttime or daytime enuresis, Willebrand-Jurgen's syndrome, hemorrhaging, diabetes insipidus, for use in oncology, for treating cancer, for treating cardiovascular diseases, antivirals, for treating inflammatory diseases of the intestine, for treating inflammatory diseases of the connective tissue, for treating arthritis, for treating urological diseases, for treating psychiatric diseases, in particular mood disorders, anxiety disorders, cognitive disorders, schizophrenia, for treating neurological and neurodegenerative diseases and disorders, in particular, dementia linked to Alzheimer's disease, Huntington's disease, Parkinson's disease, cerebral palsy, brain injuries and diseases, injuries and diseases of the spinal cord, convulsive disorders, epilepsy, encephalitis, disorders of the central nervous system, ocular motility disorders, dystonia, blepharospasm, strabismus, facial scoliosis and tics, cerebral ischemia, dementia, amyotrophic sclerosis, and lateral multiple sclerosis, for treating auto-immune diseases, for treating transplant rejection, for treating ophthalmological diseases such as proliferative or non-proliferative diabetic retinopathy, macular degeneration, age-related macular degeneration, retinal neovascularization, neovascularization associated with choroidal melanoma, retinopathy, central retinal vein occlusion, pigmentary retinitis, uveitis, macular edema, cystoid macular edema, peptides;

NICTUR

Pharmaceutical preparations for human use for treating nighttime or daytime enuresis, primary nocturnal enuresis, nocturia, Von Willebrand-Jurgens disease, hemorrhaging, bleeding in patients with Hemophilia A, postoperative bleeding and diabetes insipidus, for the management of surgical hemostasis, for use in renal concentrating capacity test, for use in oncology, for treating cancer, for treating cardiovascular diseases, for use as antivirals, for treating inflammatory diseases and disorders of the intestine, for treating inflammatory diseases and disorders of the connective tissue, for treating arthritis, for treating urological diseases and disorders, for treating hormonal diseases and disorders, for treating endocrinological diseases and disorders, for treating psychiatric diseases and disorders, in particular mood disorders, anxiety disorders, cognitive disorders and schizophrenia, for treating neurological and neurodegenerative diseases and disorders, in particular, dementia linked to Alzheimer's disease, Huntington's disease, Parkinson's disease, cerebral palsy, brain injuries and diseases, injuries and diseases of the spinal cord, convulsive disorders, epilepsy, encephalitis, disorders of the central nervous system, ocular motility disorders, dystonia, blepharospasm, strabismus, facial scoliosis and tics, cerebral ischemia, dementia, amyotrophic sclerosis, and lateral multiple sclerosis, for treating auto-immune diseases and disorders, for treating transplant rejection, for treating ophthalmological diseases and disorders such as proliferative or non-proliferative diabetic retinopathy, macular degeneration, age-related macular degeneration, retinal neovascularization, neovascularization associated with choroidal melanoma, retinopathy, central retinal vein occlusion, pigmentary retinitis, uveitis, macular edema and cystoid macular edema; synthetic peptides for the treatment of urological, endocrine and blood diseases and disorders;The wording NICTUR has no meaning in a foreign language.;

YAMAB

Pharmaceutical preparations for human purposes for use in urology; pharmaceutical preparations for human purposes for the prevention and treatment of disorders of the nervous system; Pharmaceutical preparations for human purposes for the treatment of inflammatory disorders; Pharmaceutical preparations for human purposes for use in oncology and in tissue and organ transplantation; pharmaceutical preparations for human purposes for the treatment of viral, cardiovascular and psychiatric related diseases and disorders; pharmaceutical preparations for human purposes for the prevention and treatment of autoimmune diseases or disorders; Pharmaceutical preparations for human purposes, namely, peptides for use in urology, oncology and for the treatment of viral, inflammatory, nervous system, cardiovascular, psychiatric and autoimmune diseases or disorders;YAM AB;